stock split
Prenetics to Execute 1-for-15 Reverse Stock Split
The move, which will take effect Nov. 13, is intended to bring the company back into compliance with Nasdaq's minimum bid listing requirement of $1 per share.
T2 Biosystems Shares Plummet After Reverse Split
The firm had effected the reverse split in order to regain compliance with Nasdaq regulations.
Oncocyte Initiates 1-for-20 Reverse Stock Split
The split will reduce the number of outstanding shares of Oncocyte's common stock to approximately 8.2 million, subject to potential adjustments.
Accelerate Diagnostics to Execute 1-for-10 Reverse Stock Split
The reverse stock split is part of the firm's plan to regain compliance with Nasdaq's minimum bid price requirement.
GeneDx to Execute 1-for-33 Reverse Stock Split
The genetic testing company, formerly known as Sema4, received a Nasdaq noncompliance notice in December as its stock has languished below $1.
Jan 5, 2023
OpGen Announces 1-for-20 Reverse Stock Split
Nov 23, 2020
HTG Molecular Completes 1-For-15 Reverse Stock Split
Aug 28, 2019
OpGen Plans Reverse Stock Split
Apr 26, 2019
Precipio to Effect 1-for-15 Reverse Stock Split
Jan 17, 2018
OpGen to Execute 1-for-25 Reverse Stock Split
Mar 16, 2017
Rosetta Genomics Announces Reverse Stock Split
Dec 28, 2016
Interpace Effecting a 1-for-10 Reverse Stock Split
Dec 23, 2016